Diabetic Peripheral Neuropathy Associated with Cardiovascular Risk Factors and Glucagon-Like Peptide-1 Concentrations Among Newly Diagnosed Patients with Type 2 Diabetes Mellitus
cardiovascular risk factors
03 medical and health sciences
0302 clinical medicine
glucagon-like peptide-1 concentrations
RC581-951
newly-diagnosed type 2 diabetes mellitus
diabetic peripheral neuropathy
Specialties of internal medicine
Targets and Therapy [Diabetes, Metabolic Syndrome and Obesity]
Original Research
3. Good health
DOI:
10.2147/dmso.s344532
Publication Date:
2022-01-05T18:10:35Z
AUTHORS (12)
ABSTRACT
Purpose: This study was aimed at the prevalence, cardiovascular risk factors of diabetic peripheral neuropathy (DPN), and relationship between DPN fasting glucagon-like peptide-1 (fGLP-1) concentrations in newly diagnosed patients with type 2 diabetes mellitus (nT2D). Methods: A cross-sectional descriptive conducted from 2015 to 2020 a population 473 nT2D. Screening for based on United Kingdom screening test. fGLP-1 measured by enzyme-linked immunosorbent assay. Results: The prevalence 26.6%, which mild grade 17.3%, moderate 8.2% severe 1.1% total. Age (OR = 1.73, 95% CI 1.12– 2.67, p 0.012), smoking 1.64, 1.03– 2.62, 0.037), poor control HbA1c 2.66, 1.23– 5.76, 0.01), 24-h urinary albumin (24hUA) 2.49, 1.26– 4.94, 0.007), retinopathy 3.17, 1.46– 6.89, 0.002) significantly increased DPN. In multivariate logistic regression analysis, hypertension 2.96, 1.16– 7.55, 0.023), triglyceride 1.50, 1.11– 2.03, 0.009), 0.85, 0.75– 0.95, 0.005), 0.79, 0.67– 0.93, 0.005) correlated were reduced (p < 0.001). particular, male had lower levels than those without Conclusion: among nT2D 26.6%. Age, smoking, hypertension, control, triglyceride, albumin, 24hUA, associated DPN, negatively 0.005). Keywords: mellitus, neuropathy, factors,
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (60)
CITATIONS (22)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....